Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer

被引:75
|
作者
Liu, Yuanda [1 ]
Li, Changfeng [1 ]
Lu, Yaoping [2 ]
Liu, Chang [1 ]
Yang, Wei [2 ]
机构
[1] Jilin Univ, Dept Endoscopy Ctr, China Japan Union Hosp, Changchun, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
immune tolerance; tumor microenvironment; gastric cancer; immunotherapy; tumor-infiltrating immune cells; EPITHELIAL-MESENCHYMAL TRANSITION; NATURAL-KILLER-CELLS; T-CELLS; GASTROESOPHAGEAL JUNCTION; PATHOLOGICAL FUNCTIONS; M2; POLARIZATION; PROMOTES; MACROPHAGES; FIBROBLASTS; ACTIVATION;
D O I
10.3389/fimmu.2022.1016817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor microenvironment is the general term for all non-cancer components and their metabolites in tumor tissue. These components include the extracellular matrix, fibroblasts, immune cells, and endothelial cells. In the early stages of tumors, the tumor microenvironment has a tumor suppressor function. As the tumor progresses, tumor immune tolerance is induced under the action of various factors, such that the tumor suppressor microenvironment is continuously transformed into a tumor-promoting microenvironment, which promotes tumor immune escape. Eventually, tumor cells manifest the characteristics of malignant proliferation, invasion, metastasis, and drug resistance. In recent years, stress effects of the extracellular matrix, metabolic and phenotypic changes of innate immune cells (such as neutrophils, mast cells), and adaptive immune cells in the tumor microenvironment have been revealed to mediate the emerging mechanisms of immune tolerance, providing us with a large number of emerging therapeutic targets to relieve tumor immune tolerance. Gastric cancer is one of the most common digestive tract malignancies worldwide, whose mortality rate remains high. According to latest guidelines, the first-line chemotherapy of advanced gastric cancer is the traditional platinum and fluorouracil therapy, while immunotherapy for gastric cancer is extremely limited, including only Human epidermal growth factor receptor 2 (HER-2) and programmed death ligand 1 (PD-L1) targeted drugs, whose benefits are limited. Clinical experiments confirmed that cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), vascular endothelial growth factor receptor (VEGFR) and other targeted drugs alone or in combination with other drugs have limited efficacy in patients with advanced gastric cancer, far less than in lung cancer, colon cancer, and other tumors. The failure of immunotherapy is mainly related to the induction of immune tolerance in the tumor microenvironment of gastric cancer. Therefore, solving the immune tolerance of tumors is key to the success of gastric cancer immunotherapy. In this study, we summarize the latest mechanisms of various components of the tumor microenvironment in gastric cancer for inducing immune tolerance and promoting the formation of the malignant phenotype of gastric cancer, as well as the research progress of targeting the tumor microenvironment to overcome immune tolerance in the treatment of gastric cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer
    Ge, Penglei
    Wang, Weiwei
    Li, Lin
    Zhang, Gong
    Gao, Zhiqiang
    Tang, Zhe
    Dang, Xiaowei
    Wu, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [22] The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
    Becerril-Rico, Jared.
    Alvarado-Ortiz, Eduardo
    Toledo-Guzman, Mariel E.
    Pelayo, Rosana
    Ortiz-Sanchez, Elizabeth
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [23] Nanomedicines modulate the tumor immune microenvironment for cancer therapy
    Chao, Po-Han
    Chan, Vanessa
    Li, Shyh-Dar
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (12) : 1719 - 1733
  • [24] The role of senescence genes in the treatment, prognosis, and tumor microenvironment of gastric cancer
    Xuan, Jinfeng
    Li, Feng
    Li, Jiongxian
    Gong, Chao
    Li, Jiaming
    Mo, Zhenchang
    Jin, Qinwen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (12): : 6926 - 6938
  • [25] Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
    Holthof, Lisa C.
    Mutis, Tuna
    CANCERS, 2020, 12 (04)
  • [26] Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering
    Yang, Jieru
    Zhu, Jiaojiao
    Lu, Shan
    Qin, Hong
    Zhou, Wenhu
    JOURNAL OF CONTROLLED RELEASE, 2025, 382
  • [27] Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts
    Wang, Ji
    Cheng, Frank H. C.
    Tedrow, Jessica
    Chang, Wennan
    Zhang, Chi
    Mitra, Anirban K.
    CANCERS, 2020, 12 (11) : 1 - 20
  • [28] Oxidative stress and autophagy-mediated immune patterns and tumor microenvironment infiltration characterization in gastric cancer
    Liu, Jifeng
    Zhang, Biao
    Zhang, Yunshu
    Zhao, Huahui
    Chen, Xu
    Zhong, Lei
    Shang, Dong
    AGING-US, 2023, 15 (21): : 12513 - 12536
  • [29] The Mechanism of the Development of Macrophage Tolerance in Tumor Microenvironment
    Podlesnaya, P. A.
    Kovaleva, O., V
    Petrenko, A. A.
    Grachev, A. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 172 (05) : 653 - 657
  • [30] Effects of Inflammation on the Immune Microenvironment in Gastric Cancer
    Zhao, Weidan
    Liu, Mingqing
    Zhang, Mingyue
    Wang, Yachen
    Zhang, Yingli
    Wang, Shiji
    Zhang, Nan
    FRONTIERS IN ONCOLOGY, 2021, 11